IL5 and airway hyperresponsiveness: While eosinophilic inflammation in the airway of COPD patients has recently attracted significant clinical attention, we previously demonstrated that NEt-4IB significantly suppressed airway hyperresponsiveness and eosinophil accumulation in the airways [20] and attenuated the levels of IL-5, IL-13, and NO in BAL fluid.